News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
341,060 Results
Type
Article (67887)
Company Profile (494)
Press Release (272657)
Multimedia
Podcasts (138)
Webinars (30)
Section
Business (90614)
Career Advice (877)
Deals (17738)
Drug Delivery (135)
Drug Development (33506)
Employer Resources (53)
FDA (5977)
Job Trends (6472)
News (135076)
Policy (12801)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (37)
2027 BioCapital Standard (4)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
40 Under 40 (1)
Academia (703)
Academic (2)
Accelerated approval (53)
ADA (47)
Adcomms (21)
Allergies (147)
Alliances (13713)
ALS (216)
Alzheimer's disease (1088)
Antibody-drug conjugate (ADC) (613)
Approvals (6667)
Artificial intelligence (761)
ASCO (229)
Autoimmune disease (391)
Automation (59)
Bankruptcy (197)
Belgium (35)
Best Places to Work (5273)
BIO (34)
Biologics (88)
Biomarkers (1)
BIOSECURE Act (14)
Biosimilars (225)
BioSpace Insights (120)
Biotechnology (318)
Bispecific (46)
Bladder cancer (215)
Brain cancer (71)
Breast cancer (752)
Cancer (6167)
Cardiovascular disease (512)
Career advice (776)
Career pathing (26)
CAR-T (331)
CDC (30)
CDMO (78)
Celiac Disease (5)
Cell therapy (880)
Cervical cancer (51)
Clinical research (34199)
Collaboration (1954)
Commercialization (54)
Company closure (5)
Compensation (1286)
Complete response letters (66)
COVID-19 (998)
CRISPR (107)
CRO (4)
C-suite (1144)
Cystic fibrosis (103)
Data (8791)
Decentralized trials (1)
Denatured (53)
Depression (165)
Dermatology (160)
Diabetes (604)
Diagnostics (3268)
Digital health (59)
Diversity (12)
Diversity, equity & inclusion (14)
Drug discovery (372)
Drug pricing (149)
Drug shortages (17)
Duchenne muscular dystrophy (257)
Earnings (55348)
Editorial (51)
Employer branding (6)
Employer resources (50)
ESMO (418)
Events (47280)
Executive appointments (983)
Eye disease (24)
FDA (9761)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (5)
Friedreich's ataxia (17)
Frontotemporal dementia (32)
Funding (1708)
Gene editing (216)
Generative AI (67)
Gene therapy (626)
GLP-1 (1153)
Government (1680)
Grass and pollen (6)
Guidances (410)
Healthcare (7462)
Hematology (233)
HIV (95)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (116)
Immunology and inflammation (294)
Immuno-oncology (117)
Indications (239)
Infectious disease (1306)
Inflammatory bowel disease (189)
Inflation Reduction Act (11)
Influenza (117)
Intellectual property (261)
Interviews (150)
IPO (10444)
IRA (35)
Job creations (1515)
Job search strategy (655)
JPM (18)
Kidney cancer (27)
Kidney disease (123)
Labor market (86)
Layoffs (318)
Leadership (34)
Legal (2983)
Licensing (105)
Liver cancer (72)
Longevity (32)
Lung cancer (884)
Lung diease (26)
Lymphoma (490)
Machine learning (52)
Management (19)
Manufacturing (1009)
Marketing (32)
MASH (207)
Medical affairs (4)
Medical device (5966)
Medtech (6190)
Melanoma (101)
Mergers & acquisitions (8565)
Metabolic disorders (1583)
Middle East (2)
mRNA (150)
Multiple sclerosis (204)
Multispecific (4)
NASH (18)
Netherlands (31)
Neurodegenerative disease (432)
Neuropsychiatric disorders (104)
Neuroscience (2676)
Neurotech (3)
NextGen: Class of 2026 (2637)
Non-profit (1265)
Now hiring (61)
Obesity (739)
Opinion (160)
Ovarian cancer (230)
Pain (238)
Pancreatic cancer (354)
Parkinson's disease (343)
Partnered (26)
Patents (529)
Patient advocacy (8)
Patient recruitment (684)
Patient selection (87)
Peanut (46)
People (16040)
Peptides (37)
Pharmaceutical (79)
Pharmacy benefit managers (30)
Phase 1 (9517)
Phase 2 (14479)
Phase 3 (12423)
Pipeline (11680)
Policy (205)
Postmarket research (1767)
Preclinical (4009)
Press Release (74)
Prostate cancer (313)
Psychedelics (67)
Radioligand (1)
Radiopharmaceuticals (256)
Rare diseases (1066)
Real estate (1796)
Recruiting (21)
Regenerative medicine (26)
Regulatory (13124)
Reports (55)
Research institute (709)
Resumes & cover letters (125)
Rett syndrome (55)
RNA editing (17)
RSV (81)
Saudi Arabia (1)
Schizophrenia (178)
Series A (282)
Series B (201)
Service/supplier (17)
Sickle cell disease (109)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (26)
Startups (1296)
State (1)
Stem cells (7)
Stomach cancer (15)
Substance use disorders (17)
Supply chain (112)
Switzerland (16)
Tariffs (55)
Tax incentives (1)
The Weekly (84)
Vaccines (747)
Venture capital (117)
Weight loss (512)
Wet AMD (6)
Women's health (131)
Women in leadership (2)
Worklife (15)
Date
Today (103)
Last 7 days (669)
Last 30 days (3104)
Last 365 days (24222)
2026 (22304)
2025 (24611)
2024 (21478)
2023 (17227)
2022 (21451)
2021 (22023)
2020 (20208)
2019 (16686)
2018 (12764)
2017 (14293)
2016 (13831)
2015 (15952)
2014 (12811)
2013 (11792)
2012 (12543)
2011 (12445)
2010 (11327)
Location
Africa (659)
Alabama (65)
Alaska (5)
Arizona (311)
Arkansas (13)
Asia (20581)
Australia (3969)
California (13228)
Canada (3123)
China (1452)
Colorado (572)
Connecticut (580)
Delaware (469)
Europe (49182)
Florida (1881)
Georgia (398)
Hawaii (5)
Idaho (38)
Illinois (1151)
India (107)
Indiana (596)
Iowa (27)
Japan (643)
Kansas (97)
Kentucky (53)
Louisiana (61)
Maine (75)
Maryland (1389)
Massachusetts (9379)
Michigan (350)
Minnesota (617)
Mississippi (7)
Missouri (132)
Montana (26)
Nebraska (16)
Nevada (172)
New Hampshire (73)
New Jersey (3598)
New Mexico (31)
New York (3352)
North Carolina (1581)
North Dakota (12)
Northern California (6704)
Ohio (415)
Oklahoma (17)
Oregon (32)
Pennsylvania (2329)
Puerto Rico (25)
Rhode Island (44)
South America (715)
South Carolina (62)
South Dakota (1)
Southern California (5313)
Tennessee (224)
Texas (2226)
United States (45623)
Utah (364)
Vermont (2)
Virginia (346)
Washington D.C. (51)
Washington State (935)
West Virginia (4)
Wisconsin (167)
Wyoming (5)
341,060 Results for "transmed7 llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
TransMed7, LLC Announces First Revenue from Concorde Family of Devices
TransMed7, LLC announced the first sales of Concorde ) Soft Tissue Biopsy devices, to the Margaret West Comprehensive Breast Center in Germantown, TN.
September 6, 2023
·
4 min read
Biotech Bay
TransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch
TransMed7, LLC announced today that the “First in Human” series of clinical cases using commercial production Concorde US devices.
February 6, 2023
·
5 min read
Biotech Bay
TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch
TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production version of a Heron™ XPS device (a member of the new Heron™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Soft Tissue Biopsy devices) was successfully performed by Dr. Edgar Staren.
August 16, 2022
·
6 min read
Biotech Bay
TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch
TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the American Society of Breast Surgeons (ASBrS).
August 9, 2022
·
5 min read
Biotech Bay
TransMed7, LLC Announces First Clinical Use of VacuPac®, a New Self-Contained, Vacuum-Assist Attachment for all of its Vacuum-Assisted, Single Insertion - Multiple Collection (SIMC®) Platforms of Biopsy Devices
TransMed7, LLC announced the first clinical use of VacuPac®, a new self-contained external vacuum-assist attachment with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion – Multiple Collection breast biopsy devices.
March 21, 2023
·
6 min read
Business
TransMed7, LLC Announces First Results From Clinical Use of its Vacuum-Assisted, Single Insertion - Multiple Collection (SIMC™) Platform of Breast Biopsy Devices
TransMed7, LLC announced today that the first of the vacuum-assisted, Single Insertion - Multiple Collection (SIMC™) breast biopsy procedures utilizing its SpeedBird 38 soft tissue biopsy device was successfully performed by Dr. Richard Fine, a distinguished surgeon and former Chairman and President of the American Society of Breast Surgeons (ASBrS).
September 22, 2020
·
6 min read
Business
TransMed7, LLC Announces Appointment of Dr. John Simpson as Strategic Advisor to Its Board of Directors
TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of Directors.
July 30, 2018
·
4 min read
Business
TransMed7, LLC Announces Inaugural Members of Its Business Advisory Board
The TransMed7 BAB is composed of accomplished business experts offering innovative advice and dynamic perspectives that will contribute to the accomplishment of TransMed7’s tactical goals and strategic objectives.
December 11, 2017
·
6 min read
Biotech Bay
TransMed7, LLC Announces the Availability of Concorde, the Stereotactic Table Variant of its SpeedBird Biopsy Device Platform
“We are delighted to announce a letter-to-file regarding ConcordeTM, the stereotactic table variant of our FDA-cleared SpeedBirdTM soft tissue biopsy device platform,” stated Dr. James W. Vetter, TransMed7 Co-Founder and Chairman.
September 18, 2018
·
5 min read
FDA
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform
The SpeedBird platform is based on TransMed7’s patented Zero5TM work element composed of a fused, single element constructed from 3 hypotubes and forming rotating twin cutter blades.
June 20, 2018
·
4 min read
1 of 34,106
Next